104 related articles for article (PubMed ID: 3178805)
1. Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo).
Mannironi C; D'Incalci M
Biochem Biophys Res Commun; 1988 Sep; 155(3):1221-9. PubMed ID: 3178805
[TBL] [Abstract][Full Text] [Related]
2. Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline.
Broggini M; Grandi M; Ubezio P; Geroni C; Giuliani FC; D'Incalci M
Biochem Pharmacol; 1988 Dec; 37(23):4423-31. PubMed ID: 3202888
[TBL] [Abstract][Full Text] [Related]
3. DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and -resistant human colon carcinoma cells.
Capolongo L; Belvedere G; D'Incalci M
Cancer Chemother Pharmacol; 1990; 25(6):430-4. PubMed ID: 2311171
[TBL] [Abstract][Full Text] [Related]
4. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
[TBL] [Abstract][Full Text] [Related]
5. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
[TBL] [Abstract][Full Text] [Related]
6. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
7. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
Rivoltini L; Colombo MP; Supino R; Ballinari D; Tsuruo T; Parmiani G
Int J Cancer; 1990 Oct; 46(4):727-32. PubMed ID: 1976601
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.
Dolfini E; Dasdia T; Arancia G; Molinari A; Calcabrini A; Scheper RJ; Flens MJ; Gariboldi MB; Monti E
Br J Cancer; 1997; 76(1):67-76. PubMed ID: 9218735
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine as a modulator of resistance to doxorubicin in human colon-adenocarcinoma cells.
Bearzatto A; Saino A; Zaffaroni N; Costa A; Santi S
Int J Oncol; 1996 Jul; 9(1):57-63. PubMed ID: 21541481
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure.
La Porta CA; Dolfini E; Comolli R
Br J Cancer; 1998 Nov; 78(10):1283-7. PubMed ID: 9823967
[TBL] [Abstract][Full Text] [Related]
11. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
12. Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cells.
Silvestrini R; Zaffaroni N; Costa A; Orlandi L; Villa R; Hendriks HR
Int J Cancer; 1993 Oct; 55(4):636-9. PubMed ID: 8406992
[TBL] [Abstract][Full Text] [Related]
13. Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.
Conforti G; Codegoni AM; Scanziani E; Dolfini E; Dasdia T; Calza M; Caniatti M; Broggini M
Br J Cancer; 1995 Mar; 71(3):505-11. PubMed ID: 7880731
[TBL] [Abstract][Full Text] [Related]
14. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1.
Wesołowska O; Wiśniewski J; Sroda K; Krawczenko A; Bielawska-Pohl A; Paprocka M; Duś D; Michalak K
Eur J Pharmacol; 2010 Oct; 644(1-3):32-40. PubMed ID: 20633549
[TBL] [Abstract][Full Text] [Related]
15. Phorbol 12-myristate 13-acetate (pma) induces neuroendocrine-like differentiation and reverses Doxorubicin-resistance of human colon-carcinoma cells in-vitro.
Correale P; Caraglia M; Pepe S; Ricciardi B; Barile C; Montagnani S; Pacelli R; Bianco A; Tagliaferri P
Int J Oncol; 1994 Feb; 4(2):423-7. PubMed ID: 21566941
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
17. Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells.
Pannocchia A; Revelli S; Tamponi G; Giorgianni A; Todde R; Bosia A; Ghigo D
Cell Biochem Funct; 1996 Mar; 14(1):11-8. PubMed ID: 8907249
[TBL] [Abstract][Full Text] [Related]
18. Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment.
Radajewska A; Moreira H; Bęben D; Siwiela O; Szyjka A; Gębczak K; Nowak P; Frąszczak J; Emhemmed F; Muller CD; Barg E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298495
[TBL] [Abstract][Full Text] [Related]
19. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods.
Yang LY; Trujillo JM
Cancer Res; 1990 Jun; 50(11):3218-25. PubMed ID: 2334917
[TBL] [Abstract][Full Text] [Related]
20. Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines.
Facchetti I; Grandi M; Cucchi P; Geroni C; Penco S; Vigevani A
Anticancer Drug Des; 1991 Nov; 6(5):385-97. PubMed ID: 1764162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
